The U.S. topical pain relief market was valued at $2,612 million in 2019, and is projected to reach $3,272 million by 2027 at a CAGR of 3.7% from 2020 to 2027.
The global ibuprofen market was valued at $100.0 million in 2023, and is projected to reach $213.6 million by 2033, growing at a CAGR of 7.9% from 2024 to 2033.
